Previous 10 | Next 10 |
Summary Cardinal Health, Inc. reported an increasing top line growth but indicated some profitability weakness due to a slowing margin. It continues to post improvements in the Pharma segment, which accounted for 92% of overall sales this quarter. Cardinal Health's bottom line...
Summary In today's issue of the 1-Minute Market Report, I examine the market bounce since the October low, and highlight the areas of the market that are leading the way higher. On Thursday, for every stock that was down, there were 26 that were up. For the first time since August...
Summary Several factors make Berkshire Hathaway competitive as a core holding, including the fact that its big winners overpower its losers as in market cap weighted S&P 500. Because acquisitions don't trade once on the Berkshire books, they don't become overpriced and risky; ...
Summary Healthcare industry, especially the large-cap pharmaceutical, biotechnology, and managed healthcare stocks are doing well and outperforming the market. More stocks in THQ’s top 70 percent equity portfolio generated high positive price growth than the number of stock...
Image source: The Motley Fool. McKesson (NYSE: MCK) Q2 2023 Earnings Call Nov 01, 2022 , 4:30 p.m. ET Operator Continue reading For further details see: McKesson (MCK) Q2 2023 Earnings Call Transcript
McKesson Corporation (MCK) Q2 2023 Earnings Conference Call November 1, 2022, 04:30 PM ET Company Participants Rachel Rodriguez - VP, IR Brian Tyler - CEO Britt Vitalone - CFO Conference Call Participants Eric Percher - Nephron Research Michael Ch...
McKesson ( NYSE: MCK ) boosted its fiscal 2023 financial guidance in terms of its adjusted earnings per diluted share due to its Q2 results. McKesson ( MCK ) now expects adjusted EPS diluted of $24.45 to $24.95, up from the previous range of $23.95 to $24.65 (consensus...
The following slide deck was published by McKesson Corporation in conjunction with their 2023 Q2 earnings call. For further details see: McKesson Corporation 2023 Q2 - Results - Earnings Call Presentation
McKesson press release ( NYSE: MCK ): Q2 Non-GAAP EPS of $6.06 misses by $0.03 . Revenue of $70.2B (+5.4% Y/Y) beats by $120M . Fiscal 2023 Outlook: • Increased fiscal 2023 Adjusted Earnings per Diluted Share guidance range to $24.45 to $24.95, from the ...
McKesson Corporation (NYSE: MCK) has released its fiscal 2023 second-quarter financial results. Results can be accessed on McKesson’s Investor Relations website at investor.mckesson.com/financials/quarterly-results . As previously announced, the company will host a live w...
News, Short Squeeze, Breakout and More Instantly...
The Board of Directors of McKesson Corporation (NYSE:MCK) yesterday declared a regular dividend of $0.71 per share of common stock, a 15% increase from $0.62 per share in the prior quarter. The dividend will be payable on October 1, 2024, to stockholders of record on September 2, 2024. ȁ...
2024-07-29 02:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...